{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:21:42Z","timestamp":1792783302798,"version":"4.5.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Grants from the National Natural Science Foundation of China","award":["No.81871231"],"award-info":[{"award-number":["No.81871231"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018627","name":"Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China","doi-asserted-by":"publisher","award":["No.2019KJK016"],"award-info":[{"award-number":["No.2019KJK016"]}],"id":[{"id":"10.13039\/501100018627","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shandong Taishan Scholars Young Experts Program","award":["No.tsqn202103056"],"award-info":[{"award-number":["No.tsqn202103056"]}]},{"name":"The Natural Science Foundation of Shandong Province","award":["No.ZR2023MH082"],"award-info":[{"award-number":["No.ZR2023MH082"]}]},{"name":"Qingdao Natural Science Foundation Key Project","award":["24-8-4-zrjj-8-jch"],"award-info":[{"award-number":["24-8-4-zrjj-8-jch"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03439-8","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:45:42Z","timestamp":1791459942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RBM protein family: Focusing on the occurrence, progression and treatment of cancer"],"prefix":"10.1007","volume":"43","author":[{"given":"Huhu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhui","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5545-9674","authenticated-orcid":false,"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"issue":"3","key":"3439_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41580-025-00914-4","volume":"27","author":"W Miao","year":"2026","unstructured":"Miao W, et al. Regulation of RNA-binding proteins by small biomolecules. Nat Rev Mol Cell Biol. 2026;27(3):213\u201333.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3439_CR2","doi-asserted-by":"publisher","first-page":"100032","DOI":"10.1016\/j.gmg.2024.100032","volume":"12","author":"AT Aborode","year":"2025","unstructured":"Aborode AT, et al. RNA binding proteins (RBPs) on genetic stability and diseases. Global Med Genet. 2025;12(1):100032.","journal-title":"Global Med Genet"},{"issue":"1","key":"3439_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.cell.2020.08.036","volume":"183","author":"L Jiang","year":"2020","unstructured":"Jiang L, et al. A Quantitative Proteome Map of the Human Body. Cell. 2020;183(1):269\u2013e28319.","journal-title":"Cell"},{"issue":"24","key":"3439_CR4","doi-asserted-by":"publisher","first-page":"11159","DOI":"10.7150\/thno.44389","volume":"10","author":"M Zhang","year":"2020","unstructured":"Zhang M, et al. Rbm24 modulates adult skeletal muscle regeneration via regulation of alternative splicing. Theranostics. 2020;10(24):11159\u201377.","journal-title":"Theranostics"},{"issue":"13","key":"3439_CR5","doi-asserted-by":"publisher","first-page":"22235","DOI":"10.18632\/oncotarget.14755","volume":"8","author":"RB Zhou","year":"2017","unstructured":"Zhou RB, et al. RNA binding motif protein 3: a potential biomarker in cancer and therapeutic target in neuroprotection. Oncotarget. 2017;8(13):22235\u201350.","journal-title":"Oncotarget"},{"issue":"5","key":"3439_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrm.2017.130","volume":"19","author":"MW Hentze","year":"2018","unstructured":"Hentze MW, et al. A brave new world of RNA-binding proteins. Nat Rev Mol Cell Biol. 2018;19(5):327\u201341.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3439_CR7","unstructured":"regulation-of-gene-expression-by-rnabinding-proteins.pdf."},{"issue":"7","key":"3439_CR8","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.trecan.2017.05.003","volume":"3","author":"B Pereira","year":"2017","unstructured":"Pereira B, Billaud M, Almeida R. RNA-Binding Proteins in Cancer: Old Players and New Actors. Trends Cancer. 2017;3(7):506\u201328.","journal-title":"Trends Cancer"},{"issue":"2","key":"3439_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1615\/JEnvironPatholToxicolOncol.2017019366","volume":"36","author":"VV Prabhu","year":"2017","unstructured":"Prabhu VV, Devaraj N. Regulating RNA Binding Motif 5 Gene Expression- A Novel Therapeutic Target for Lung Cancer. J Environ Pathol Toxicol Oncol. 2017;36(2):99\u2013105.","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"3439_CR10","doi-asserted-by":"publisher","first-page":"103067","DOI":"10.1016\/j.ebiom.2020.103067","volume":"61","author":"S Zhang","year":"2020","unstructured":"Zhang S, et al. RNA binding motif protein 10 suppresses lung cancer progression by controlling alternative splicing of eukaryotic translation initiation factor 4H. EBioMedicine. 2020;61:103067.","journal-title":"EBioMedicine"},{"issue":"7","key":"3439_CR11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jgg.2021.05.006","volume":"48","author":"XC Xu","year":"2021","unstructured":"Xu XC, et al. RNA-binding motif protein RBM47 promotes tumorigenesis in nasopharyngeal carcinoma through multiple pathways. J Genet Genomics. 2021;48(7):595\u2013605.","journal-title":"J Genet Genomics"},{"issue":"5","key":"3439_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41388-023-02902-4","volume":"43","author":"C Wang","year":"2024","unstructured":"Wang C, et al. RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1\/ACSL4. Oncogene. 2024;43(5):328\u201340.","journal-title":"Oncogene"},{"key":"3439_CR13","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.2147\/IJGM.S519741","volume":"18","author":"X Long","year":"2025","unstructured":"Long X, et al. RNA Binding Motif Protein 15 (RBM15): Structure, Function and Its Research Progress in Tumors. Int J Gen Med. 2025;18:3635\u201349.","journal-title":"Int J Gen Med"},{"issue":"1","key":"3439_CR14","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.1038\/s41467-022-32176-5","volume":"13","author":"JH Badrani","year":"2022","unstructured":"Badrani JH, et al. RNA-binding protein RBM3 intrinsically suppresses lung innate lymphoid cell activation and inflammation partially through CysLT1R. Nat Commun. 2022;13(1):4435.","journal-title":"Nat Commun"},{"key":"3439_CR15","doi-asserted-by":"publisher","first-page":"3037337","DOI":"10.1155\/2021\/3037337","volume":"2021","author":"C Fu","year":"2021","unstructured":"Fu C, et al. RNA-Binding Motif Protein 11 (RBM11) Serves as a Prognostic Biomarker and Promotes Ovarian Cancer Progression. Dis Markers. 2021;2021:3037337.","journal-title":"Dis Markers"},{"issue":"1","key":"3439_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.trecan.2025.10.002","volume":"12","author":"L Harrison-Oakes","year":"2026","unstructured":"Harrison-Oakes L, Igiogbe W, Nguyen DTT. Functional plasticity of RNA-binding proteins in cancer: both friend and foe. Trends Cancer. 2026;12(1):80\u201394.","journal-title":"Trends Cancer"},{"key":"3439_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ymeth.2016.11.009","volume":"118\u2013119","author":"D Benhalevy","year":"2017","unstructured":"Benhalevy D, et al. PAR-CLIP and streamlined small RNA cDNA library preparation protocol for the identification of RNA binding protein target sites. Methods. 2017;118\u2013119:41\u20139.","journal-title":"Methods"},{"issue":"7","key":"3439_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nrc.2016.51","volume":"16","author":"H Dvinge","year":"2016","unstructured":"Dvinge H, et al. RNA splicing factors as oncoproteins and tumour suppressors. Nat Rev Cancer. 2016;16(7):413\u201330.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"3439_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri I, Kouzarides T. Role of RNA modifications in cancer. Nat Rev Cancer. 2020;20(6):303\u201322.","journal-title":"Nat Rev Cancer"},{"key":"3439_CR20","doi-asserted-by":"publisher","first-page":"145463","DOI":"10.1016\/j.gene.2021.145463","volume":"783","author":"A Inoue","year":"2021","unstructured":"Inoue A. RBM10: Structure, functions, and associated diseases. Gene. 2021;783:145463.","journal-title":"Gene"},{"issue":"3","key":"3439_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/nar\/30.3.623","volume":"30","author":"ZJ Lorkovi\u0107","year":"2002","unstructured":"Lorkovi\u0107 ZJ, Barta A. Genome analysis: RNA recognition motif (RRM) and K homology (KH) domain RNA-binding proteins from the flowering plant Arabidopsis thaliana. Nucleic Acids Res. 2002;30(3):623\u201335.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3439_CR22","doi-asserted-by":"publisher","first-page":"100032","DOI":"10.1016\/j.gmg.2024.100032","volume":"12","author":"AT Aborode","year":"2025","unstructured":"Aborode AT, et al. RNA binding proteins (RBPs) on genetic stability and diseases. Glob Med Genet. 2025;12(1):100032.","journal-title":"Glob Med Genet"},{"key":"3439_CR23","doi-asserted-by":"crossref","unstructured":"Roy S et al. Structural and dynamic studies of the human RNA binding protein RBM3 reveals the molecular basis of its oligomerization and RNA recognition. 2022. 289(10): pp. 2847\u201364.","DOI":"10.1111\/febs.16301"},{"issue":"41","key":"3439_CR24","doi-asserted-by":"publisher","first-page":"14536","DOI":"10.1021\/ja507690d","volume":"136","author":"Z Cienikov\u00e1","year":"2014","unstructured":"Cienikov\u00e1 Z, et al. Structural and mechanistic insights into poly(uridine) tract recognition by the hnRNP C RNA recognition motif. J Am Chem Soc. 2014;136(41):14536\u201344.","journal-title":"J Am Chem Soc"},{"issue":"26","key":"3439_CR25","doi-asserted-by":"publisher","first-page":"e2506275122","DOI":"10.1073\/pnas.2506275122","volume":"122","author":"L Hemm","year":"2025","unstructured":"Hemm L, et al. The RRM domain-containing protein Rbp3 interacts with ribosomes and the 3\u2019 ends of mRNAs encoding photosynthesis proteins. Proc Natl Acad Sci U S A. 2025;122(26):e2506275122.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"3439_CR26","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1080\/15476286.2021.1909320","volume":"18","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. The distinct roles of zinc finger CCHC-type (ZCCHC) superfamily proteins in the regulation of RNA metabolism. RNA Biol. 2021;18(12):2107\u201326.","journal-title":"RNA Biol"},{"issue":"8","key":"3439_CR27","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.molcel.2024.02.039","volume":"84","author":"A Damianov","year":"2024","unstructured":"Damianov A, et al. The splicing regulators RBM5 and RBM10 are subunits of the U2 snRNP engaged with intron branch sites on chromatin. Mol Cell. 2024;84(8):1496\u2013e15117.","journal-title":"Mol Cell"},{"issue":"1","key":"3439_CR28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.str.2015.10.029","volume":"24","author":"BT Martin","year":"2016","unstructured":"Martin BT, et al. Nuclear Magnetic Resonance Structure of a Novel Globular Domain in RBM10 Containing OCRE, the Octamer Repeat Sequence Motif. Structure. 2016;24(1):158\u201364.","journal-title":"Structure"},{"issue":"1","key":"3439_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12964-021-00741-y","volume":"19","author":"J Lu","year":"2021","unstructured":"Lu J, et al. Types of nuclear localization signals and mechanisms of protein import into the nucleus. Cell Commun Signal. 2021;19(1):60.","journal-title":"Cell Commun Signal"},{"issue":"7795","key":"3439_CR30","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41586-020-1974-9","volume":"578","author":"F Dossin","year":"2020","unstructured":"Dossin F, et al. SPEN integrates transcriptional and epigenetic control of X-inactivation. Nature. 2020;578(7795):455\u201360.","journal-title":"Nature"},{"issue":"17","key":"3439_CR31","doi-asserted-by":"publisher","first-page":"10683","DOI":"10.1093\/nar\/gkae713","volume":"52","author":"FF Damberger","year":"2024","unstructured":"Damberger FF, et al. N-terminal domain of polypyrimidine-tract binding protein is a dynamic folding platform for adaptive RNA recognition. Nucleic Acids Res. 2024;52(17):10683\u2013704.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3439_CR32","doi-asserted-by":"publisher","first-page":"lqae002","DOI":"10.1093\/nargab\/lqae002","volume":"6","author":"J Roca-Mart\u00ednez","year":"2024","unstructured":"Roca-Mart\u00ednez J, et al. Analysis of the inter-domain orientation of tandem RRM domains with diverse linkers: connecting experimental with AlphaFold2 predicted models. NAR Genom Bioinform. 2024;6(1):lqae002.","journal-title":"NAR Genom Bioinform"},{"issue":"18","key":"3439_CR33","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.1016\/j.cell.2025.06.021","volume":"188","author":"MW Hentze","year":"2025","unstructured":"Hentze MW, et al. Rethinking RNA-binding proteins: Riboregulation challenges prevailing views. Cell. 2025;188(18):4811\u201327.","journal-title":"Cell"},{"issue":"5","key":"3439_CR34","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1261\/rna.044081.113","volume":"20","author":"YS Tsai","year":"2014","unstructured":"Tsai YS, Gomez SM, Wang Z. Prevalent RNA recognition motif duplication in the human genome. RNA. 2014;20(5):702\u201312.","journal-title":"RNA"},{"issue":"1","key":"3439_CR35","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1038\/s41467-023-39961-w","volume":"14","author":"K Soni","year":"2023","unstructured":"Soni K, et al. Structural basis for specific RNA recognition by the alternative splicing factor RBM5. Nat Commun. 2023;14(1):4233.","journal-title":"Nat Commun"},{"issue":"3","key":"3439_CR36","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1083\/jcb.201007131","volume":"193","author":"JC Lin","year":"2011","unstructured":"Lin JC, Tarn WY. RBM4 down-regulates PTB and antagonizes its activity in muscle cell-specific alternative splicing. J Cell Biol. 2011;193(3):509\u201320.","journal-title":"J Cell Biol"},{"issue":"5","key":"3439_CR37","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.molcel.2013.11.010","volume":"52","author":"EG Bechara","year":"2013","unstructured":"Bechara EG, et al. RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation. Mol Cell. 2013;52(5):720\u201333.","journal-title":"Mol Cell"},{"key":"3439_CR38","doi-asserted-by":"crossref","unstructured":"Wang Y, Wang Z. Targeting dysregulated splicing factors in cancer: lessons learned from RBM10 deficiency. J Mol Cell Biol, 2023. 15(10).","DOI":"10.1093\/jmcb\/mjad063"},{"issue":"6","key":"3439_CR39","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s12276-024-01235-w","volume":"56","author":"SH Park","year":"2024","unstructured":"Park SH, et al. The m(6)A writer RBM15 drives the growth of triple-negative breast cancer cells through the stimulation of serine and glycine metabolism. Exp Mol Med. 2024;56(6):1373\u201387.","journal-title":"Exp Mol Med"},{"key":"3439_CR40","doi-asserted-by":"publisher","first-page":"105421","DOI":"10.1016\/j.nbd.2021.105421","volume":"156","author":"J van der Zee","year":"2021","unstructured":"van der Zee J, et al. Family-based exome sequencing identifies RBM45 as a possible candidate gene for frontotemporal dementia and amyotrophic lateral sclerosis. Neurobiol Dis. 2021;156:105421.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"3439_CR41","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cell.2020.05.034","volume":"182","author":"Q Wang","year":"2020","unstructured":"Wang Q, et al. Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase. Cell. 2020;182(2):417\u2013e42813.","journal-title":"Cell"},{"issue":"42","key":"3439_CR42","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1038\/s41388-023-02795-3","volume":"42","author":"D Du","year":"2023","unstructured":"Du D, et al. RNA binding motif protein 45-mediated phosphorylation enhances protein stability of ASCT2 to promote hepatocellular carcinoma progression. Oncogene. 2023;42(42):3127\u201341.","journal-title":"Oncogene"},{"issue":"5","key":"3439_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1615\/CritRevEukaryotGeneExpr.2024052205","volume":"34","author":"R Wang","year":"2024","unstructured":"Wang R, Tan W. RBM15-Mediated N6-Methyl Adenosine (m6A) Modification of EZH2 Drives the Epithelial-Mesenchymal Transition of Cervical Cancer. Crit Rev Eukaryot Gene Expr. 2024;34(5):15\u201329.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"8","key":"3439_CR44","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.1016\/j.cllc.2024.07.010","volume":"25","author":"A Reyes","year":"2024","unstructured":"Reyes A, et al. RBM10 Mutation as a Potential Negative Prognostic\/Predictive Biomarker to Therapy in Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2024;25(8):e411\u20139.","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"3439_CR45","doi-asserted-by":"publisher","first-page":"12761","DOI":"10.1038\/s41598-025-97869-5","volume":"15","author":"L An","year":"2025","unstructured":"An L, et al. RBM10 suppresses colorectal cancer invasion by regulating LncRNA SNHG17 alternative splicing. Sci Rep. 2025;15(1):12761.","journal-title":"Sci Rep"},{"issue":"15","key":"3439_CR46","doi-asserted-by":"publisher","first-page":"e35001","DOI":"10.1016\/j.heliyon.2024.e35001","volume":"10","author":"X Sun","year":"2024","unstructured":"Sun X, Jia D, Yu Y. Down regulation of RBM10 promotes proliferation and metastasis via miR-224-5p\/RBM10\/p53 feedback loop in lung adenocarcinoma. Heliyon. 2024;10(15):e35001.","journal-title":"Heliyon"},{"issue":"6","key":"3439_CR47","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1111\/jcmm.14263","volume":"23","author":"X Jin","year":"2019","unstructured":"Jin X, et al. RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1\/AKT\/CREB signalling pathway. J Cell Mol Med. 2019;23(6):3897\u2013904.","journal-title":"J Cell Mol Med"},{"key":"3439_CR48","doi-asserted-by":"crossref","unstructured":"He Y et al. CREB3 suppresses hepatocellular carcinoma progression by depressing AKT signaling through competitively binding with insulin receptor and transcriptionally activating RNA-binding motif protein 38. MedComm (2020), 2024. 5(7): p. e633.","DOI":"10.1002\/mco2.633"},{"key":"3439_CR49","doi-asserted-by":"publisher","first-page":"757135","DOI":"10.3389\/fonc.2021.757135","volume":"11","author":"Z Li","year":"2021","unstructured":"Li Z, et al. The RNA-Binding Motif Protein Family in Cancer: Friend or Foe? Front Oncol. 2021;11:757135.","journal-title":"Front Oncol"},{"issue":"1","key":"3439_CR50","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41420-023-01623-7","volume":"9","author":"Q Su","year":"2023","unstructured":"Su Q, et al. RBM47 restrains renal cell carcinoma progression and chemoresistance through interacting with lncRNA HOXB-AS1. Cell Death Discov. 2023;9(1):329.","journal-title":"Cell Death Discov"},{"key":"3439_CR51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biochi.2023.03.001","volume":"211","author":"Q Ma","year":"2023","unstructured":"Ma Q, et al. Wnt\/\u03b2-catenin signaling pathway-a versatile player in apoptosis and autophagy. Biochimie. 2023;211:57\u201367.","journal-title":"Biochimie"},{"issue":"1","key":"3439_CR52","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1186\/s12967-024-05970-6","volume":"22","author":"Y Ma","year":"2024","unstructured":"Ma Y, et al. RBM47 promotes cell proliferation and immune evasion by upregulating PDIA6: a novel mechanism of pancreatic cancer progression. J Transl Med. 2024;22(1):1164.","journal-title":"J Transl Med"},{"issue":"7","key":"3439_CR53","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.4251\/wjgo.v16.i7.3241","volume":"16","author":"CX Wang","year":"2024","unstructured":"Wang CX, Liu F, Wang Y. RBM5 suppresses proliferation, metastasis and glycolysis of colorectal cancer cells via stabilizing phosphatase and tensin homolog mRNA. World J Gastrointest Oncol. 2024;16(7):3241\u201355.","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"3439_CR54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13059-023-03149-8","volume":"25","author":"M Zhang","year":"2024","unstructured":"Zhang M, et al. RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9. Genome Biol. 2024;25(1):16.","journal-title":"Genome Biol"},{"issue":"2","key":"3439_CR55","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41419-023-05627-0","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang S, et al. RBM3 suppresses stemness remodeling of prostate cancer in bone microenvironment by modulating N6-methyladenosine on CTNNB1 mRNA. Cell Death Dis. 2023;14(2):91.","journal-title":"Cell Death Dis"},{"key":"3439_CR56","doi-asserted-by":"publisher","first-page":"e18761429323760","DOI":"10.2174\/0118761429323760240712050006","volume":"17","author":"Y Huang","year":"2024","unstructured":"Huang Y, et al. RBM3 Inhibits the Cell Cycle of Cutaneous Squamous Cell Carcinoma through the PI3K\/AKT Signaling Pathway. Curr Mol Pharmacol. 2024;17:e18761429323760.","journal-title":"Curr Mol Pharmacol"},{"issue":"19","key":"3439_CR57","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1016\/j.molcel.2024.07.019","volume":"84","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Ai Y, Abdel-Wahab O. Molecular impact of mutations in RNA splicing factors in cancer. Mol Cell. 2024;84(19):3667\u201380.","journal-title":"Mol Cell"},{"issue":"1","key":"3439_CR58","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.1038\/s41467-024-50882-0","volume":"15","author":"FE Machour","year":"2024","unstructured":"Machour FE, et al. Harnessing DNA replication stress to target RBM10 deficiency in lung adenocarcinoma. Nat Commun. 2024;15(1):6417.","journal-title":"Nat Commun"},{"issue":"6","key":"3439_CR59","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1158\/0008-5472.CAN-17-2457","volume":"78","author":"J Zhang","year":"2018","unstructured":"Zhang J, et al. Genetic Ablation of Rbm38 Promotes Lymphomagenesis in the Context of Mutant p53 by Downregulating PTEN. Cancer Res. 2018;78(6):1511\u201321.","journal-title":"Cancer Res"},{"issue":"7\u20138","key":"3439_CR60","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1101\/gad.346148.120","volume":"35","author":"W Sun","year":"2021","unstructured":"Sun W, et al. Fine-tuning p53 activity by modulating the interaction between eukaryotic translation initiation factor eIF4E and RNA-binding protein RBM38. Genes Dev. 2021;35(7\u20138):542\u201355.","journal-title":"Genes Dev"},{"issue":"1","key":"3439_CR61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00018-020-03593-w","volume":"78","author":"C Zou","year":"2021","unstructured":"Zou C, et al. RBM38 in cancer: role and mechanism. Cell Mol Life Sci. 2021;78(1):117\u201328.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"3439_CR62","doi-asserted-by":"publisher","first-page":"26685","DOI":"10.1038\/s41598-025-05151-5","volume":"15","author":"G Liu","year":"2025","unstructured":"Liu G, et al. RBM47 functions as an anti-oncogene by regulating expression and alternative splicing of cell proliferation and apoptosis associated genes in colorectal cancer cells. Sci Rep. 2025;15(1):26685.","journal-title":"Sci Rep"},{"issue":"1","key":"3439_CR63","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13046-024-03030-x","volume":"43","author":"J Chang","year":"2024","unstructured":"Chang J, et al. RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated \u03b2-catenin signaling in cholangiocarcinoma. J Exp Clin Cancer Res. 2024;43(1):104.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"3439_CR64","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/bjc.2017.204","volume":"117","author":"J Wu","year":"2017","unstructured":"Wu J, et al. RBM38 is involved in TGF-\u03b2-induced epithelial-to-mesenchymal transition by stabilising zonula occludens-1 mRNA in breast cancer. Br J Cancer. 2017;117(5):675\u201384.","journal-title":"Br J Cancer"},{"issue":"1","key":"3439_CR65","doi-asserted-by":"publisher","first-page":"7367","DOI":"10.1038\/s41598-018-25668-2","volume":"8","author":"J Pilotte","year":"2018","unstructured":"Pilotte J, et al. Morphoregulatory functions of the RNA-binding motif protein 3 in cell spreading, polarity and migration. Sci Rep. 2018;8(1):7367.","journal-title":"Sci Rep"},{"issue":"1","key":"3439_CR66","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1186\/s12967-024-05970-6","volume":"22","author":"Y Ma","year":"2024","unstructured":"Ma Y, et al. RBM47 promotes cell proliferation and immune evasion by upregulating PDIA6: a novel mechanism of pancreatic cancer progression. J Translational Med. 2024;22(1):1164.","journal-title":"J Translational Med"},{"issue":"12","key":"3439_CR67","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1182\/blood.2019003764","volume":"137","author":"H Han","year":"2021","unstructured":"Han H, et al. piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL. Blood. 2021;137(12):1603\u201314.","journal-title":"Blood"},{"issue":"1","key":"3439_CR68","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/s41467-022-28741-7","volume":"13","author":"A Lopez","year":"2022","unstructured":"Lopez A, et al. Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer. Nat Commun. 2022;13(1):1199.","journal-title":"Nat Commun"},{"issue":"34","key":"3439_CR69","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1038\/s41388-025-03390-4","volume":"44","author":"H Wu","year":"2025","unstructured":"Wu H, et al. RBM5 recruiting MGC32805 in a sandwich mode and inducing \u2206FAS neoantigen and triggering FAS properties switch: implication in colorectal cancer. Oncogene. 2025;44(34):3052\u201369.","journal-title":"Oncogene"},{"issue":"1","key":"3439_CR70","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41392-023-01703-1","volume":"9","author":"L Wu","year":"2024","unstructured":"Wu L, et al. Camouflaging attenuated Salmonella by cryo-shocked macrophages for tumor-targeted therapy. Signal Transduct Target Therapy. 2024;9(1):14.","journal-title":"Signal Transduct Target Therapy"},{"issue":"5","key":"3439_CR71","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1038\/s44318-026-00707-1","volume":"45","author":"T-Q Chen","year":"2026","unstructured":"Chen T-Q, et al. RBM15B recognizes H3K79me2 to guide selective m6A-modification of mRNA and enhance oncoprotein translation in MLL-r leukemia. EMBO J. 2026;45(5):1672\u201396.","journal-title":"EMBO J"},{"issue":"3","key":"3439_CR72","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccr.2014.07.010","volume":"26","author":"Y Wang","year":"2014","unstructured":"Wang Y, et al. The Splicing Factor RBM4 Controls Apoptosis, Proliferation, and Migration to Suppress Tumor Progression. Cancer Cell. 2014;26(3):374\u201389.","journal-title":"Cancer Cell"},{"key":"3439_CR73","doi-asserted-by":"publisher","first-page":"217061","DOI":"10.1016\/j.canlet.2024.217061","volume":"597","author":"L-Q Cao","year":"2024","unstructured":"Cao L-Q, et al. Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies. Cancer Lett. 2024;597:217061.","journal-title":"Cancer Lett"},{"issue":"8","key":"3439_CR74","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24(8):560\u201375.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3439_CR75","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s42003-024-06196-4","volume":"7","author":"P Dey","year":"2024","unstructured":"Dey P, et al. Cold-shock proteome of myoblasts reveals role of RBM3 in promotion of mitochondrial metabolism and myoblast differentiation. Commun Biology. 2024;7(1):515.","journal-title":"Commun Biology"},{"issue":"6","key":"3439_CR76","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","volume":"150","author":"M Imielinski","year":"2012","unstructured":"Imielinski M, et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell. 2012;150(6):1107\u201320.","journal-title":"Cell"},{"issue":"7511","key":"3439_CR77","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature13385","volume":"511","author":"EA Collisson","year":"2014","unstructured":"Collisson EA, et al. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511(7511):543\u201350.","journal-title":"Nature"},{"key":"3439_CR78","doi-asserted-by":"crossref","unstructured":"Shin HC et al. Prognostic Significance of RBM3 Expression in Epithelial Ovarian Cancer: A Tissue Microarray-Based Study. Diagnostics (Basel), 2025. 15(11).","DOI":"10.3390\/diagnostics15111426"},{"key":"3439_CR79","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.3390\/diagnostics15111426","volume":"15","author":"HC Shin","year":"2025","unstructured":"Shin HC, et al. Prognostic Significance of RBM3 Expression in Epithelial Ovarian Cancer: A Tissue Microarray-Based Study. Diagnostics. 2025;15:1426. https:\/\/doi.org\/10.3390\/diagnostics15111426.","journal-title":"Diagnostics"},{"key":"3439_CR80","doi-asserted-by":"publisher","first-page":"104544","DOI":"10.1016\/j.cryobiol.2023.05.001","volume":"112","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, et al. Study on the protective effect of RNA-binding motif protein 3 in mild hypothermia oxygen-glucose deprivation\/reoxygenation cell model. Cryobiology. 2023;112:104544.","journal-title":"Cryobiology"},{"issue":"1","key":"3439_CR81","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13046-018-0852-x","volume":"37","author":"J Ye","year":"2018","unstructured":"Ye J, et al. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma. J Exp Clin Cancer Res. 2018;37(1):212.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3439_CR82","doi-asserted-by":"publisher","first-page":"10722","DOI":"10.1038\/s41598-025-95432-w","volume":"15","author":"L Lv","year":"2025","unstructured":"Lv L, et al. Deciphering the tumor-suppressive role of RBMS3 in lung adenocarcinoma through genomic insights into prognosis and mechanisms. Sci Rep. 2025;15(1):10722.","journal-title":"Sci Rep"},{"issue":"4","key":"3439_CR83","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1007\/s12013-025-01859-3","volume":"83","author":"Z Xin","year":"2025","unstructured":"Xin Z, Huang H, Shao Y. Function and Mechanism of the RNA-binding Protein RBMS3 in Malignant Tumours. Cell Biochem Biophys. 2025;83(4):4313\u201322.","journal-title":"Cell Biochem Biophys"},{"key":"3439_CR84","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1479-5876-8-78","volume":"8","author":"A Ehl\u00e9n","year":"2010","unstructured":"Ehl\u00e9n A, et al. Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer. J Transl Med. 2010;8:78.","journal-title":"J Transl Med"},{"key":"3439_CR85","doi-asserted-by":"crossref","unstructured":"He B et al. miR\u2013383 increases the cisplatin sensitivity of lung adenocarcinoma cells through inhibition of the RBM24\u2013mediated NF\u2013\u03baB signaling pathway. Int J Oncol, 2021. 59(5).","DOI":"10.3892\/ijo.2021.5267"},{"key":"3439_CR86","doi-asserted-by":"crossref","unstructured":"Park S et al. Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer. eBioMedicine, 2024. 102.","DOI":"10.1016\/j.ebiom.2024.105062"},{"key":"3439_CR87","doi-asserted-by":"publisher","first-page":"108033","DOI":"10.1016\/j.lungcan.2024.108033","volume":"198","author":"Z Yu","year":"2024","unstructured":"Yu Z, Zou J, Xu F. The molecular subtypes of small cell lung cancer defined by key transcription factors and their clinical significance. Lung Cancer. 2024;198:108033.","journal-title":"Lung Cancer"},{"issue":"8","key":"3439_CR88","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.ccell.2025.07.008","volume":"43","author":"CS Dai","year":"2025","unstructured":"Dai CS, et al. Circulating tumor cells: Blood-based detection, molecular biology, and clinical applications. Cancer Cell. 2025;43(8):1399\u2013422.","journal-title":"Cancer Cell"},{"key":"3439_CR89","doi-asserted-by":"publisher","first-page":"100297","DOI":"10.1016\/j.jlb.2025.100297","volume":"8","author":"T Velpula","year":"2025","unstructured":"Velpula T, Buddolla V. Enhancing detection and monitoring of circulating tumor cells: Integrative approaches in liquid biopsy advances. J Liquid Biopsy. 2025;8:100297.","journal-title":"J Liquid Biopsy"},{"issue":"4","key":"3439_CR90","first-page":"852","volume":"119","author":"T Mercher","year":"2009","unstructured":"Mercher T, et al. The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model. J Clin Invest. 2009;119(4):852\u201364.","journal-title":"J Clin Invest"},{"key":"3439_CR91","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jare.2023.11.029","volume":"65","author":"T Wang","year":"2024","unstructured":"Wang T, Zhang H. Exploring the roles and molecular mechanisms of RNA binding proteins in the sorting of noncoding RNAs into exosomes during tumor progression. J Adv Res. 2024;65:105\u201323.","journal-title":"J Adv Res"},{"issue":"1","key":"3439_CR92","doi-asserted-by":"publisher","first-page":"26881","DOI":"10.1038\/s41598-025-12725-w","volume":"15","author":"C Damodaran","year":"2025","unstructured":"Damodaran C, Cho J-Y, G\u00fcng\u00f6r C. Therapeutic resistance and combination therapy for cancer: recent developments and future directions. Sci Rep. 2025;15(1):26881.","journal-title":"Sci Rep"},{"issue":"1","key":"3439_CR93","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13148-025-01961-6","volume":"17","author":"X Yu","year":"2025","unstructured":"Yu X, et al. Regulation of cisplatin resistance in lung cancer by epigenetic mechanisms. Clin Epigenetics. 2025;17(1):145.","journal-title":"Clin Epigenetics"},{"issue":"1","key":"3439_CR94","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12885-021-09168-7","volume":"22","author":"S Wahlin","year":"2022","unstructured":"Wahlin S, et al. Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity. BMC Cancer. 2022;22(1):131.","journal-title":"BMC Cancer"},{"issue":"1","key":"3439_CR95","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10565-024-09985-z","volume":"41","author":"W Zhuang","year":"2024","unstructured":"Zhuang W, et al. RBM19 promotes the progression of prostate cancer under docetaxel treatment via SNHG21\/PIM1 axis. Cell Biol Toxicol. 2024;41(1):19.","journal-title":"Cell Biol Toxicol"},{"issue":"11","key":"3439_CR96","first-page":"3644","volume":"10","author":"Y Song","year":"2020","unstructured":"Song Y, et al. RBMX contributes to hepatocellular carcinoma progression and sorafenib resistance by specifically binding and stabilizing BLACAT1. Am J Cancer Res. 2020;10(11):3644\u201365.","journal-title":"Am J Cancer Res"},{"key":"3439_CR97","doi-asserted-by":"crossref","unstructured":"Gao X et al. RBM38 Reverses Sorafenib Resistance in Hepatocellular Carcinoma Cells by Combining and Promoting lncRNA-GAS5. Cancers (Basel), 2023. 15(11).","DOI":"10.3390\/cancers15112897"},{"issue":"2","key":"3439_CR98","doi-asserted-by":"publisher","first-page":"e24459","DOI":"10.1016\/j.heliyon.2024.e24459","volume":"10","author":"H Wang","year":"2024","unstructured":"Wang H. The RNA m6A writer RBM15 contributes to the progression of esophageal squamous cell carcinoma by regulating miR-3605-5p\/KRT4 pathway. Heliyon. 2024;10(2):e24459.","journal-title":"Heliyon"},{"issue":"15","key":"3439_CR99","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1016\/j.molcel.2023.06.024","volume":"83","author":"J Zhang","year":"2023","unstructured":"Zhang J, et al. A lncRNA from the FTO locus acts as a suppressor of the m(6)A writer complex and p53 tumor suppression signaling. Mol Cell. 2023;83(15):2692\u2013e27087.","journal-title":"Mol Cell"},{"issue":"2","key":"3439_CR100","doi-asserted-by":"publisher","first-page":"113924","DOI":"10.1016\/j.yexcr.2024.113924","volume":"436","author":"Y Quan","year":"2024","unstructured":"Quan Y, et al. The m6A methyltransferase RBM15 affects tumor cell stemness and progression of cervical cancer by regulating the stability of lncRNA HEIH. Exp Cell Res. 2024;436(2):113924.","journal-title":"Exp Cell Res"},{"issue":"4","key":"3439_CR101","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1158\/0008-5472.CAN-18-2209","volume":"79","author":"CA Lucchesi","year":"2019","unstructured":"Lucchesi CA, et al. Disruption of the Rbm38-eIF4E Complex with a Synthetic Peptide Pep8 Increases p53 Expression. Cancer Res. 2019;79(4):807\u201318.","journal-title":"Cancer Res"},{"issue":"6","key":"3439_CR102","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1158\/1535-7163.MCT-22-0627","volume":"22","author":"CA Lucchesi","year":"2023","unstructured":"Lucchesi CA, et al. Identification of a First-in-Class Small-Molecule Inhibitor of the EIF4E-RBM38 Complex That Enhances Wild-type TP53 Protein Translation for Tumor Growth Suppression. Mol Cancer Ther. 2023;22(6):726\u201336.","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"3439_CR103","doi-asserted-by":"publisher","first-page":"e1877","DOI":"10.1002\/wrna.1877","volume":"15","author":"S Schmeing","year":"2024","unstructured":"Schmeing S, Hart P. Challenges in Therapeutically Targeting the RNA-Recognition Motif. Wiley Interdiscip Rev RNA. 2024;15(6):e1877.","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"1","key":"3439_CR104","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41698-024-00610-0","volume":"8","author":"S Kohsaka","year":"2024","unstructured":"Kohsaka S, et al. A molecular glue RBM39-degrader induces synthetic lethality in cancer cells with homologous recombination repair deficiency. npj Precision Oncol. 2024;8(1):117.","journal-title":"npj Precision Oncol"},{"issue":"1","key":"3439_CR105","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41698-024-00610-0","volume":"8","author":"S Kohsaka","year":"2024","unstructured":"Kohsaka S, et al. A molecular glue RBM39-degrader induces synthetic lethality in cancer cells with homologous recombination repair deficiency. NPJ Precis Oncol. 2024;8(1):117.","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"3439_CR106","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1158\/1078-0432.CCR-10-0010","volume":"17","author":"M Mita","year":"2011","unstructured":"Mita M, et al. Phase I study of E7820, an oral inhibitor of integrin alpha-2 expression with antiangiogenic properties, in patients with advanced malignancies. Clin Cancer Res. 2011;17(1):193\u2013200.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"3439_CR107","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1158\/1078-0432.CCR-06-0249","volume":"13","author":"DC Talbot","year":"2007","unstructured":"Talbot DC, et al. A Randomized Phase II Pharmacokinetic and Pharmacodynamic Study of Indisulam as Second-Line Therapy in Patients with Advanced Non\u2013Small Cell Lung Cancer. Clin Cancer Res. 2007;13(6):1816\u201322.","journal-title":"Clin Cancer Res"},{"key":"3439_CR108","doi-asserted-by":"crossref","unstructured":"\u00c1vila-G\u00f3mez P et al. Therapeutic modulation of protein RBM3 for ischemic stroke treatment. 2025. Volume 16\u20132025.","DOI":"10.3389\/fphar.2025.1555115"},{"issue":"1","key":"3439_CR109","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s41065-025-00534-0","volume":"162","author":"J Fu","year":"2025","unstructured":"Fu J, et al. RBM15 enhances paclitaxel resistance in triple-negative breast cancer by targeting m(6)A methylation of TNFSF9 and inducing polarization of tumor-associated macrophages to M2 phenotype. Hereditas. 2025;162(1):167.","journal-title":"Hereditas"},{"key":"3439_CR110","doi-asserted-by":"publisher","first-page":"113955","DOI":"10.1016\/j.intimp.2024.113955","volume":"147","author":"R Zhu","year":"2025","unstructured":"Zhu R, et al. RBM47 as a potential therapeutic target for thyroid-associated ophthalmopathy. Int Immunopharmacol. 2025;147:113955.","journal-title":"Int Immunopharmacol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03439-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03439-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03439-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:02:11Z","timestamp":1791464531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03439-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":110,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3439"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03439-8","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent to publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"322"}}